Ncats Alliance Inc

Nonprofit profile at a glance

EIN
921746571
IRS 990-EZ coverage
2023–2025
Forms available
Form 990-EZ 2025
Location
Washington, DC, USA
Phone
2022530924
Rating
88
Verdict
STRONG
Rating confidence
Moderate
Sector
Alliance/Advocacy Organizations

Reported finances

Revenue
$107,215
Expenses
$109,325
Assets
$14,364
Liabilities
$0

Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

7 people listed

People named in this filing

  • RONALD BARTEK (CHAIR)
  • KARIN HOELZER (SECRETARY - UNTIL 03/2025)
  • PAUL MELMEYER (TREASURER)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Secure the sustained appropriations and policies necessary to further enable ncats to lead the transformation and acceleration of translational science research and development to diagnose, treat and cure rare and common diseases; and to educate policymakers, medical professionals, the medical industry, patients, and other stakeholders about the nature and vital role of ncats in translational sciences research and development in improving our health and well-being.

What it reported doing in 2025

The ncats alliance is a coalition of patient advocates, clinicians, academic medical centers, researchers, and biotechnology companies working to educate the public and policymakers on the important science advanced by the national center for advancing translational sciences (ncats). The ncats alliance board holds quarterly meetings that include presentations and updates from ncats senior staff on new scientific initiatives and federal budget and appropriations matters. The alliance also hosts annual general membership meetings for all members, a majority of whom are nonprofit rare disease patient organizations. These meetings include presentations from the ncats director and the senior scientific staff. In 2025, the ncats alliance cohosted a congressional staff tour of ncats and meetings with ncats staff to educate congress on translational science. The alliance engages in outreach to increase congress and the public's understanding of the importance of the ncats scientific mission. In 2025, the alliance designated the third week in april as ncats alliance advocacy week. Alliance members met in person with over a dozen congressional staff and launched a grassroots advocacy campaign in support of these lobbying efforts.

Operating model

Revenue model
Membership-supported. 100% of the money available for current operations came from membership dues.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

STRONG - A large share of available resources goes toward mission work and the filed numbers largely add up. Expenses are high relative to revenue and total assets are small relative to annual expenses; liquid coverage is unknown.

Rating breakdown

  • Financial Efficiency: 97
  • Transparency & Controls: 82
  • Sustainability: 32
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 97.5%; rating input score 97
  • Program expense ratio: 95.6%; rating input score 96

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
  • Major donor itemization: Limited

Sustainability

  • Operating margin: -2%; rating input score 25; 25th percentile among comparable filings
  • Total-asset coverage ratio: 0.13; rating input score 14; 14th percentile among comparable filings
  • Liabilities to assets ratio: 0; rating input score 74; 74th percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 63; 63rd percentile among comparable filings

Growth

  • Program expense growth: 9.4% per year; rating input score 100; 57th percentile among comparable filings
  • Revenue growth: 9.7% per year; rating input score 100; 63rd percentile among comparable filings
  • Asset growth: 69.9% per year; rating input score 100; 95th percentile among comparable filings

Details

  • Where the money goes: 97.5% of revenue deployed · 95.6% of spending went to programs
  • Governance: Filed governance answers
  • Accomplishments: 1 filed program accomplishment · $104K in reported program spending
  • Leadership: top reported pay $0 · 7 people listed
  • Consistency: 8 of 8 current checks pass
  • Schedules: 2 filed schedules
  • Filing history: 3 filing years from 2023 to 2025
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Sustainability: Operating margin scored 25/100.
  • High — Sustainability: Total-asset coverage ratio scored 14/100.